期刊文献+

阿立哌唑合并锂盐治疗躁狂症临床观察 被引量:2

The curative effect of aripiprazole combined with lithium on mania
下载PDF
导出
摘要 目的:探讨阿立哌唑合并锂盐治疗躁狂症的临床疗效。方法:将83例躁狂症患者随机分成阿立哌唑合并锂盐组(研究组)和锂盐组(对照组)治疗6周。于治疗前和治疗后第4天和第1、2、3、6周用Bech-Rafaelsen躁狂量表(BRMS)、临床疗效总评量表(CGI-SI)和治疗中出现的症状量表(TESS)评定病情的严重程度、疗效和不良反应。结果:研究组和对照组在治疗后第4天、1周、2周、3周后BRMS评分差异有显著性(P<0.05),研究组降分较快,不良反应相仿。结论:阿立哌唑合并锂盐治疗躁狂症出现疗效较单用锂盐快。 Objective:To study the curative effect of aripiprazole combined with lithium in treatment of mania. Method:83 manic patients were assigned into either study group which received aripiprazole plus lithium treatment or control group which received lithium treatment for six weeks.Bech-Rafaelsen mania rating scale (BRMS),clinical global impression (CGI-SI) and treatment emergent symptom scale (TESS) were conducted at baseline,day 4,week 1,2,3 and 6. Results:The study group showed more score decrease on BRMS and CGI-SI at day 4,week 1,2 and 3 (P0.05),which indicated aripiprazole combined with lithium worked faster.There were no significant side effect differences between the two groups. Conclusion: Aripiprazole combined with lithium can have earlier curative effect in treatment of mania than lithium.
出处 《临床精神医学杂志》 2011年第1期49-50,共2页 Journal of Clinical Psychiatry
关键词 阿立哌唑 锂盐 躁狂症 aripiprazole lithium mania
  • 相关文献

参考文献4

二级参考文献48

  • 1Fountoulakis KN, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. Journal of Affective Disorders, 2005 ; 86 ( 1 ) : 1-10.
  • 2Keck PE, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry, 2003; 160 (9): 1651-1658.
  • 3Bourin M, Auby P, Marcus RN, et al. Aripiprazole versus haloperidol for maintained treatment effect in acute mania. Abstract NR467 plus Poster. California: 156^th Annual Meeting of the American Psychiatric Association, 2003 ; 17-22.
  • 4Octavio I, Stock E, Archibald D, et al. Long-term effects of aripiprazole on affective symptoms of schizophrenia. Eur Neuropsychopharmacol. 2004; 14 (suppl. 3) : S261.
  • 5Thase ME, Jonas A, Khan A, et al. Aripiprazole Monotherapy in Non-Psychotic Bipolar Ⅰ Depression. J Clin Psychopharmacology, 2008 ; 28 ( 1 ) : 13-20.
  • 6McElroy SL, Suppes T, Frye MA, et al. Open-label aripiprazole in the treatment of acute bipolar depression: A prospective pilot trial. Affect Disord. 2007; 101 (1-3) : 275-281.
  • 7Dunn RT, Stan VA, Chriki IS, et al. A prospective open-label study of aripiprazole mono-and adjunctive treatment in acute bipolar depression. Affect Disord. 2008 ; doi : 10. 1016/ j.j ad. 2008.01. 004.
  • 8Kemp DE, Gilmer WS, Fleck J, et al. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. Prog Neuropsychopharmacol Biol Psychiatry, 2007 ; 31 (2) : 574-577.
  • 9Marcus RN, McQuade RD, Carson WH, et al. Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder. J Clin Psychopharmacology, 2008; 28 (2): 156-165.
  • 10Nylias M, Carson W, Forbes R, et al. Long-term efficacy and safety of aripiprazole in pediatric patients with bipolar disorder. Schizophr Res. 2008 ; 98 ( 1 ) : 48.

共引文献65

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部